# PNKD

## Overview
The PNKD gene encodes a protein known as PNKD metallo-beta-lactamase domain containing, which is characterized by its metallo-beta-lactamase domain. This domain is a hallmark of a superfamily of enzymes involved in various biochemical processes. The PNKD protein exists in multiple isoforms, including long (PNKD-L), medium (PNKD-M), and short (PNKD-S) forms, due to alternative splicing. The long isoform, PNKD-L, is predominantly expressed in the central nervous system and plays a critical role in cellular redox regulation, potentially through the detoxification of alpha-ketonaldehyde products using reduced glutathione. PNKD-L is associated with the cell membrane and endosomes, suggesting its involvement in membrane protein trafficking and vesicle recycling, which are essential for neuronal function. Mutations in the PNKD gene are linked to paroxysmal nonkinesigenic dyskinesia, a movement disorder characterized by episodic dystonia and chorea, highlighting the gene's clinical significance in neurological conditions (Shen2011Mutations; Lee2012Dopamine).

## Structure
The PNKD gene encodes a protein with a metallo-beta-lactamase domain, which is a characteristic feature of its structure. This domain is conserved among a superfamily of enzymes and is crucial for the protein's enzymatic activity (Shen2011Mutations). The PNKD protein exists in multiple isoforms due to alternative splicing, including long (PNKD-L), medium (PNKD-M), and short (PNKD-S) forms. The long and medium isoforms contain the metallo-beta-lactamase domain at the C-terminus, while the short isoform lacks homology to any known protein (Shen2011Mutations).

PNKD-L is specifically expressed in the central nervous system and is involved in cellular redox regulation, potentially through a reaction that regenerates reduced glutathione (Shen2011Mutations). The localization of PNKD-L to the cell membrane and endosomes suggests a role in vesicle recycling or membrane protein transport in neurons (Shen2011Mutations). Mutations in PNKD, such as single amino acid changes, affect protein stability and cleavage, leading to more rapid degradation and decreased levels of PNKD-L in the cortex (Shen2011Mutations). These structural and functional characteristics highlight the importance of the metallo-beta-lactamase domain and the impact of alternative splicing on the protein's role in neurological functions.

## Function
The PNKD gene encodes a protein that plays a crucial role in maintaining cellular redox status and protecting neurons from oxidative stress. The long isoform of the PNKD protein, PNKD-L, is expressed in the central nervous system and is involved in detoxifying alpha-ketonaldehyde products using reduced glutathione (GSH) as a co-factor. This detoxification process is essential for maintaining cellular redox balance and protecting neurons from oxidative damage (Shen2011Mutations).

PNKD-L is localized to the cell membrane and endosomes in CNS neurons, suggesting its involvement in membrane protein trafficking, which is crucial for neuronal function (Shen2011Mutations). The protein is also implicated in vesicle recycling or membrane protein transport, processes vital for proper neuronal communication and function (Shen2011Mutations).

In healthy human cells, the PNKD protein undergoes cleavage at its N-terminus, a process important for its stability and function. Mutations in the PNKD gene can lead to altered protein cleavage and stability, resulting in faster degradation of the protein, which may contribute to disease states (Shen2011Mutations).

## Clinical Significance
Mutations in the PNKD gene are associated with paroxysmal nonkinesigenic dyskinesia (PNKD), a rare autosomal dominant movement disorder characterized by episodic attacks of dystonia, chorea, and athetosis. These episodes can be triggered by stress, fatigue, or the consumption of alcohol or caffeine (Pons2012Paroxysmal; Shen2011Mutations). The disorder is linked to specific mutations in the PNKD protein, particularly single amino acid changes such as A7V, A9V, and A33P, which affect the stability and processing of the protein, leading to faster degradation compared to the wild-type (Shen2011Mutations).

The PNKD protein is involved in modulating neurotransmitter release, particularly dopamine, in the central nervous system. Mutations in PNKD can lead to altered dopamine signaling, contributing to the pathophysiology of PNKD (Lee2012Dopamine). The disorder exhibits incomplete penetrance and intrafamilial variability, with some individuals carrying the mutation without showing symptoms (Pons2012Paroxysmal).

In addition to PNKD, mutations in the PNKD gene have been implicated in other conditions, such as paroxysmal kinesigenic dyskinesia (PKD) with seizures, episodic ataxia, familial hemiplegic migraine, and Tourette Syndrome (Liao2021Genetic). These findings highlight the clinical significance of PNKD mutations in various neurological disorders.

## Interactions
The PNKD protein, associated with paroxysmal nonkinesigenic dyskinesia, is involved in several interactions that are crucial for its function in the central nervous system. PNKD is a membrane-associated protein that may modulate neurotransmitter release at nigrostriatal dopaminergic terminals or influence striatal glutamatergic inputs from the cerebral cortex and thalamus (Lee2012Dopamine). The interactions between adenosine receptors, dopamine receptors, metabotropic glutamate receptors, and cannabinoid receptors are essential for normal striatal function and plasticity, suggesting that dysfunction in these interactions could contribute to PNKD pathophysiology (Lee2012Dopamine).

The long isoform of PNKD (PNKD-L) is involved in detoxifying a-ketonaldehyde products in cells using glutathione as a co-factor, which may play a role in maintaining cellular redox status and protecting neurons from stress conditions (Shen2011Mutations). PNKD-L's localization to the cell membrane and endosomes suggests its involvement in vesicle recycling or membrane protein transport in CNS neurons (Shen2011Mutations). Mutations in PNKD-L affect its protein stability and cleavage, leading to altered interactions with cellular components and potentially impacting motor circuits (Shen2011Mutations).


## References


[1. (Pons2012Paroxysmal) Roser Pons, Ester Cuenca-León, Elena Miravet, Montse Pons, Athina Xaidara, Sotiris Youroukos, and Alfons Macaya. Paroxysmal non-kinesigenic dyskinesia due to a pnkd recurrent mutation: report of two southern european families. European Journal of Paediatric Neurology, 16(1):86–89, January 2012. URL: http://dx.doi.org/10.1016/j.ejpn.2011.09.008, doi:10.1016/j.ejpn.2011.09.008. This article has 20 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ejpn.2011.09.008)

[2. (Liao2021Genetic) James Y. Liao, Philippe A. Salles, Umar A. Shuaib, and Hubert H. Fernandez. Genetic updates on paroxysmal dyskinesias. Journal of Neural Transmission, 128(4):447–471, April 2021. URL: http://dx.doi.org/10.1007/s00702-021-02335-x, doi:10.1007/s00702-021-02335-x. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00702-021-02335-x)

[3. (Shen2011Mutations) Yiguo Shen, Hsien-Yang Lee, Joel Rawson, Sunil Ojha, Patricia Babbitt, Ying-Hui Fu, and Louis J. Ptáček. Mutations in pnkd causing paroxysmal dyskinesia alters protein cleavage and stability. Human Molecular Genetics, 20(12):2322–2332, April 2011. URL: http://dx.doi.org/10.1093/hmg/ddr125, doi:10.1093/hmg/ddr125. This article has 48 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddr125)

[4. (Lee2012Dopamine) Hsien-yang Lee, Junko Nakayama, Ying Xu, Xueliang Fan, Maha Karouani, Yiguo Shen, Emmanuel N. Pothos, Ellen J. Hess, Ying-Hui Fu, Robert H. Edwards, and Louis J. Ptácek. Dopamine dysregulation in a mouse model of paroxysmal nonkinesigenic dyskinesia. Journal of Clinical Investigation, 122(2):507–518, February 2012. URL: http://dx.doi.org/10.1172/jci58470, doi:10.1172/jci58470. This article has 50 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci58470)